selective serotonin reuptake inhibitor (SSRI)
Showing 1 - 25 of >10,000
Major Depressive Disorder With Anhedonia and Inadequate Response
Not yet recruiting
- Depressive Disorder, Major
- No Intervention
- (no location specified)
Apr 24, 2023
Haemorrhage Between Vortioxetine Tablet Treatment and Selective
Not yet recruiting
- Major Depressive Disorder
- Vortioxetine Tablet
- SSRI
- (no location specified)
Jun 28, 2023
Depressive Disorder, Major, Treatment Resistant Depression, Melancholia Trial in Ghent (device, behavioral, drug)
Recruiting
- Depressive Disorder, Major
- +2 more
- aiTBS
- +2 more
-
Ghent, East-Flanders, BelgiumUniversity Hospital Ghent
Dec 6, 2022
Risk Factors for AD-Associated Switch to Mania
Completed
- Bipolar Disorder
- Selective Serotonin Reuptake Inhibitors (SSRI), Serotonin-Norepinephrine Reuptake Inhibitor( SNRI), and Tricyclics.
-
Barcelona, Catalonia, SpainHospital Clinic Barcelona
Nov 17, 2021
SSRI's and the Rate of Progression From MCI to Dementia
Recruiting
- Mild Cognitive Impairment
- +2 more
-
Columbus, OhioThe Ohio State University
Sep 8, 2021
Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)
Recruiting
- Depressive Disorder, Major
- Seltorexant
- Placebo
-
San Diego, California
- +26 more
Aug 17, 2022
Major Depressive Disorder Who Have HadInadequate Response
Terminated
- Depressive Disorder, Major
- Standard of Care (SOC)
-
San Francisco, California
- +3 more
Dec 6, 2022
Depressive Disorder, Major Trial in United States (JNJ-42847922, Placebo Matching to JNJ-42847922, Quetiapine XR)
Selective Serotonin Reuptake Inhibitor on Cognition, Sexual
Recruiting
- Menopause
- Hormone replacement therapy
- Selective serotonin reuptake inhibitors
-
São Bernardo do Campo, SP, BrazilCentro de Atenção Integral à Saúde da Mulher
Jan 20, 2022
Depressive Disorder, Major Trial in Worldwide (Esketamine 28 mg, Esketamine 56 mg, Esketamine 84 mg)
Completed
- Depressive Disorder, Major
- Esketamine 28 mg
- +6 more
-
Ciudad Autonoma de Buenos Aires, Argentina
- +170 more
Sep 13, 2022
Hypercapnia, Ventilatory Depression Trial in West Bend (Placebo and Oxycodone, Paroxetine and Oxycodone, Escitalopram and
Not yet recruiting
- Hypercapnia
- Ventilatory Depression
- Placebo and Oxycodone
- +2 more
-
West Bend, WisconsinSpaulding Clinical Research
Jul 20, 2022
Stroke, Ischemic Trial in White Plains (Administration of SSRI escitalopram, Paired Associative stimulation, Administration of
Withdrawn
- Stroke, Ischemic
- Administration of SSRI escitalopram
- +2 more
-
White Plains, New YorkBurke Neurological Institute
Jul 19, 2021
Fibromyalgia, Depression Trial in Dokki (Physiotherapy protocol, Selective serotonin reuptake inhibitors (SSRI))
Not yet recruiting
- Fibromyalgia
- Depression
- Physiotherapy protocol
- Selective serotonin reuptake inhibitors (SSRI)
-
Dokki, EgyptOutpatient clinic faculty of physica therapy cairo university
Mar 24, 2023
Depression, Serotonin Deficiency Trial in Kelowna (Pharmacological agent: Citalopram, Placebo)
Not yet recruiting
- Depression
- Serotonin Deficiency
- Pharmacological agent: Citalopram
- Placebo
-
Kelowna, British Columbia, CanadaUniversity of British Columbia, Okanagan Campus
Jul 19, 2023
Obesity, Depression Trial in Lucerne (Roux-en-Y gastric bypass, sleeve gastrectomy)
Completed
- Obesity
- Depression
- Roux-en-Y gastric bypass, sleeve gastrectomy
-
Lucerne, SwitzerlandLuzerner Kantonsspital
Jun 9, 2021
Bipolar Disorder, Major Depression Trial in Cleveland (Selective Serotonin Reuptake Inhibitor (SSRI))
Completed
- Bipolar Disorder
- Major Depression
- Selective Serotonin Reuptake Inhibitor (SSRI)
-
Cleveland, OhioCleveland Clinic Foundation Center for Behavioral Health
Nov 26, 2019
OCD Trial in Dhaka (N-acetylcysteine tablet 600mg, Placebo tablet 600mg)
Recruiting
- OCD
- N-acetylcysteine tablet 600mg
- Placebo tablet 600mg
-
Dhaka, Bangladesh
- +1 more
Nov 14, 2021
Depressive Disorder, Major Trial in Worldwide (Esketamine, SSRI/SNRI)
Active, not recruiting
- Depressive Disorder, Major
-
Ciudad Autonoma de Buenos Aires, Argentina
- +58 more
Jan 31, 2023
Retinal Nerve Fiber Layer in First Episode Depressive Patients
Enrolling by invitation
- Unipolar Depression
-
Diyarbakır, TurkeySağlık Bilimleri Üniversitesi Gazi Yaşargil Tranining and Resear
Mar 16, 2021
MDD Trial in Hangzhou (SSRI, SIA, AIA)
Recruiting
- Major Depressive Disorder
- SSRI
- +2 more
-
Hangzhou, Zhejiang, Chinathe Third affiliated hospital of Zhejiang Chinese Medical univer
Jan 31, 2023
Percutaneous Tracheostomy in Clopidogrel and Selective Serotonin
Withdrawn
- Tracheostomy Complication
-
Columbus, Ohio
- +1 more
Nov 2, 2021
MDD Trial in Hangzhou (SSRI, SIA, AIA)
Recruiting
- Major Depressive Disorder
- SSRI
- +2 more
-
Hangzhou, Zhejiang, Chinathe Third affiliated hospital of Zhejiang Chinese Medical univer
Apr 15, 2023
MDD Trial in Dhaka (Magnesium Glycinate tablet 200mg, Placebo tablet 200mg)
Completed
- MDD
- Magnesium Glycinate tablet 200mg
- Placebo tablet 200mg
-
Dhaka, BangladeshBasic Science and Paraclinical Science of BSMMU
Mar 6, 2022
Depression in Old Age, Fragility Fracture Trial in Winston-Salem (Duloxetine 30 mg)
Not yet recruiting
- Depression in Old Age
- Fragility Fracture
- Duloxetine 30 mg
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
May 9, 2023